Go back
Sakura Finetek USA launches 6 new ready-to-use antibodies for the Tissue-Tek Genie® Advanced Staining System.
Product launch
February 13, 2023
America
TORRANCE, CA – Sakura Finetek USA, Inc. today announced the launch of 6 new ready-to-use antibodies for the Tissue-Tek Genie
® Advanced Staining System.
“Sakura Finetek USA’s commitment to increasing our optimal quality ready-to-use antibody menu for IHC is vital to our mission of improving the clinical value and utility of the Genie product line. In addition to broadening our portfolio with these 6 antibodies, we have further improved the performance of our anti-Ki67 antibody by offering an additional clone choice as well as changing our anti-CD3 antibody from a rabbit monoclonal to a mouse monoclonal, both of which received an optimal score from NordiQC”, stated William Jennings MBA, Senior Product Manager of Advanced Staining.
The 6 new products include:
- Tissue-Tek Genie® anti-CD3 Mouse Monoclonal Antibody [ZM45]
- Tissue-Tek Genie® anti-Uroplakin II Mouse Monoclonal Antibody [BC21]
- Tissue-Tek Genie® anti-Ki67 Mouse Monoclonal Antibody [GM027]
- Tissue-Tek Genie® anti-MUC5AC Mouse Monoclonal Antibody [Nd-2]
- Tissue-Tek Genie® anti-Myogenin Mouse Monoclonal Antibody [F5D]
- Tissue-Tek Genie® anti-MUC2 Mouse Monoclonal Antibody [CCP58]
Like the wide range of antibodies launched previously, these new antibodies are provided in 2 formats to serve any laboratory size and workflow:
- Innovative single-use capsules that enable loading of any slide, any stain, any time, on any instrument
- Cartridges with 250 tests for high volume usage.
About the Genie System
Quality that excites. Sakura Finetek partnered with NordiQC (
www.nordiqc.org), a world-leading external quality assurance institute, to assure optimal stain quality for our entire menu of antibodies. The species and clones of Genie antibodies have been carefully selected and proficiently developed to meet our rigorous standards. The stain protocols for Genie antibodies provide exceptional sensitivity and specificity to enable accurate assessment of patients’ specimens by pathologists.
Stop sorting, gain time. With its 30 fully independent staining stations, the Genie offers true random access and does not slow down when more slides are added. Users can eliminate time-consuming slide sorting or grouping, and instead simply load their next most important slide or case.
Flexibility that liberates. Laboratories can use Genie’s unique and innovative single-use
capsules for antibodies or probes and load them on Genie’s independent staining stations together with the slides. The 250-test Genie Pro Detection Systems (DAB, AP Red, DUO) and antibody cartridges are loaded onto the system’s carousel, which deliver the reagents in constant timed cycles guaranteeing predictable workflow. Genie enables users to realize flexibility, better economy, and faster turnaround time.
Fast to learn, easy to operate. The Genie Software uses intuitive graphics and two mouse-
click navigation for simplified operation, and provides a comprehensive status at a glance. The replacement of bulk reagents and waste bottles is quick and strain-free.
About Sakura Finetek, USA, Inc.
With its U.S. office based in Torrance, California, Sakura Finetek is the global leader in advancing cancer diagnostics by providing integrated solutions for anatomic pathology and patient treatment through best-in-class innovation, quality, and customer care. With a strategic focus on end-to-end automation, Sakura Finetek continues to lead the industry in the development and commercialization of automated histopathology instrumentation and consumables for anatomic pathology.
Sakura Finetek systems dramatically increase efficiency, standardize results, and enable clinical laboratories to more simply manage their daily workload while significantly impacting patient care. Visit
www.sakuraus.com to learn more.
Erico von Bueren MD PhD MOR
Senior Director of Marketing and Strategy
Sakura Finetek USA, Inc.
1750 W. 214th St.
Torrance, CA 90501
evonbueren@sakuraus.com